mm

About Jason Novak

Jason has been a consistent contributor to VectorVest and has a blended interest in technology and finance, which he has written about for over a decade. When he's not demystifying complex financial topics or sharing a quick analysis of hot stocks on a given day, you may find him on the golf course or exploring all that Northern California has to offer.
9 08, 2024

Nasdaq Technical Analysis: How to Analyze the Nasdaq or its Indices

By |2024-08-07T00:27:14+00:00August 9th, 2024|Categories: Stock Market|Tags: |

Whether you’re trading individual stocks on the Nasdaq or its indices, having a reliable approach for how to analyze a stock before buying can make or break your success. Proper Nasdaq technical analysis helps you uncover winning opportunities on a consistent basis while informing your buy and sell decisions and timing your trades to perfection. [...]

8 08, 2024

Eli Lilly Climbs 8% on Impressive Earnings and Upbeat Outlook as Drug Sales Surge: Time to Buy?

By |2024-08-08T16:14:58+00:00August 8th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , , |

Eli Lilly & Co. (LLY) is up more than 8% so far Thursday morning after reporting second-quarter earnings that easily surpassed the Wall Street consensus. The company also raised its guidance for the full year. The drugmaker posted adjusted earnings per share of $3.92, well ahead of the $2.60 that was expected by analysts. [...]

7 08, 2024

CVS Falls After Disappointing Earnings as Healthcare-Benefits Struggle: Time to Sell?

By |2024-08-07T16:06:12+00:00August 7th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , , , , |

CVS Health Corporation (CVS) is down 1% today, making it an 8% loss on the week so far. The company’s latest earnings painted another disappointing picture, this time, as the healthcare-benefits segment struggled. The company’s net income of $1.77 billion was quite a step back from $1.90 billion this time last year. This worked [...]

7 08, 2024

How to Trade Nasdaq Stocks or Indices

By |2024-08-07T00:27:21+00:00August 7th, 2024|Categories: Stock Market|Tags: |

There are so many different stocks you can invest in as you begin building a stock portfolio - VectorVest tracks more than 16,000 of them! Yet, those listed on the Nasdaq are among the most exciting opportunities. These represent the highest-performance companies from the tech sector along with businesses from healthcare, consumer goods & services, [...]

6 08, 2024

Palantir Jumps 11% on Strong Q2 Earnings Fueled By AI Demand: Why It’s Not Quite Time to Buy PLTR

By |2024-08-06T17:48:47+00:00August 6th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , , , , |

Shares of Palantir Technologies (PLTR) are up more than 11% Tuesday on the heels of an impressive second-quarter performance. The company shoved it to the naysayers with 27% growth in revenue amidst “relentless AI demand”. Adjusted earnings per share came in just above analyst expectations at $0.09 compared to $0.08. Net income of $134 [...]

5 08, 2024

Amazon’s Earnings and AI Stance Have Analysts Excited, But VectorVest Says to SELL AMZN Today

By |2024-08-05T17:21:58+00:00August 5th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , , , , |

Amazon (AMZN) reported second-quarter earnings and spoke on its growing AI business, which was enough for some analysts to stand by their price targets. But as the stock continues to fall, VectorVest sees reason to consider selling it today. The online marketplace reported revenue of $147.98 billion, just short of the $148.56 billion consensus [...]

2 08, 2024

Exxon Inches Further Away From Competitors in Q2, But it May Not Be Time to Buy XOM Yet

By |2024-08-02T16:07:35+00:00August 2nd, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , , |

Exxon Mobil (XOM) reported its second-quarter earnings results that easily surpassed analyst expectations thanks to unprecedented production in the Permian Basin and Guyana.  The $9.2 billion in earnings worked out to $2.14 per share for Exxon, a 17% improvement year over year. This was well ahead of the $2.02 analysts were expecting.  The performance [...]

31 07, 2024

AMD Climbs 5% After Beating Expectations in Q2, Sharing Optimistic Outlook: Time to Buy AMD?

By |2024-07-31T16:40:53+00:00July 31st, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , , |

Shares of Advanced Micro Devices (AMD) are up around 5% so far Wednesday morning after the chipmaker reported second-quarter results that narrowly outperformed the analyst expectations. The company’s upbeat outlook for the current quarter played a part as well. Adjusted earnings per share came in at $0.69/share, just ahead of the $0.68/share estimate on [...]

30 07, 2024

JetBlue Posts Unexpected Profit That Has Shares Climbing 18% Higher: Is it Time to Buy JBLU?

By |2024-07-30T17:25:14+00:00July 30th, 2024|Categories: Feature: Stock Market Investing, Featured: News, Stock Market News|Tags: , , , , , , , , , |

JetBlue Airways (JBLU) reported its second-quarter results Tuesday, featuring a pleasant surprise on the bottom line. The earnings beat sent shares climbing 18% higher so far this morning. The company delivered a profit of $25 million or 8 cents a share, which was well below its performance this time last year of $138 million [...]

Go to Top